← All indications
Cardiac Output, Low
A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.
Drugs by status
Approved for this indication (1)
Phase 4 trials (9)
Phase 3 trials (5)
Phase 2 trials (2)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (5)
Organization Involved with Phase 3 Indications (25)
- Innogene Kalbiotech Pte. Ltd
- Tenax Therapeutics, Inc.
- Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
- Duke University
- Universidad Complutense de Madrid
- University of Seville
- University of Sussex
- University of Birmingham
- Jiao Tong University
- Badalona Hospital Germans Trias i Pujol
- British Heart Foundation
- University of Lubeck
- Mario Negri Institute
- University of Valladolid
- University of Coruna
- Universite Joseph Fourier
- Harapan Kita Hospital, Jakarta, Indonesia
- Orion Corporation
- Murdoch University
- Autonomous University of Madrid
- University of Malaga
- Shanghai Children Medicine Center
- Canary Foundation
- QBE Europe SA/NV
- TRIDE Asesores SL
Organization Involved with Phase 2 Indications (8)
Organization Involved with Other Experimental Indications (1)